outpatient imaging Archives - The Imaging Wire

GE to Buy Intelerad in Massive $2.3B Acquisition

Posted on November 21, 2025November 21, 2025 by Brian Casey

In what could be the biggest radiology IT acquisition in years, GE HealthCare will acquire medical image management software company Intelerad in a purchase valued at $2.3B. The acquisition will bolster GE’s position in the outpatient image management segment, which is rapidly shifting from on-premises PACS models to cloud-based environments.

Intelerad was founded in Montreal in 1999 as a PACS developer and has grown through acquisitions of its own in recent years.

U.K. private equity firm Hg took a controlling interest in Intelerad in 2020, and the company soon embarked on a series of acquisitions that rolled up smaller imaging IT companies like Digisonics (2020), Ambra Health (2021), Insignia (2021), Lumedx (2021), Life Image (2022), and PenRad Technologies (2022).

After taking a few years to digest the new companies, Intelerad began focusing on moving its technology and customers to cloud-based architecture, such as by releasing a cloud-native version of its InteleHeart software and by moving its PACS, VNA, and image-sharing applications to AWS cloud hosting.

GE needs no introduction, of course, but the company clearly sees the attraction of Intelerad’s core market in outpatient imaging, which complements GE’s focus on larger hospitals and health systems.

In a conversation with The Imaging Wire, Scott Miller, president and CEO, Solutions for Enterprise Imaging at GE HealthCare, explained several of the acquisition’s advantages …

Imaging exams are moving from hospitals to outpatient centers due to lower costs.
Outpatient facilities are following hospitals in moving their data to the cloud, putting Intelerad at the intersection of two major trends.
Intelerad’s geographic focus has been on English-speaking countries, giving GE the opportunity to plug Intelerad products into its international distribution network.

GE estimates that Intelerad will generate $270M in revenue in its first full year under GE ownership.

Intelerad’s sales have been growing at a rate in the low double digits, and GE expects that pace to accelerate.

Is the new acquisition a sign of growing consolidation in the radiology AI and image management sectors?

Other recent purchases in 2025 include Radiology Partners’ purchase of Cognita Imaging, Lunit’s acquisition of Prognosia, and GE’s own purchase of icometrix, completed earlier this month. RadNet also acquired iCAD earlier in the year.

The Takeaway

GE’s acquisition of Intelerad offers multiple benefits to the multimodality OEM, from Intelerad’s presence in the outpatient imaging sector to its experience in cloud-based image management and broad product portfolio. The question is whether the purchase spurs other big iron vendors to answer with acquisitions of their own.

UnitedHealthcare’s Imaging Designation

Posted on February 2, 2022October 13, 2023 by Jake Fishman

UnitedHealthcare continued its war against imaging costs, introducing its new Designated Diagnostic Provider program. This program is built to drive more exams through providers that meet UnitedHealthcare’s definition of quality and cost, and could have a big impact on its imaging partners.

Designated Criteria – Hospital outpatient and freestanding imaging centers that are contracted with UHC to provide advanced imaging (MRI, CT, PET, MRA, nuclear) must apply to receive Designated Diagnostic Provider status. Imaging providers who don’t meet UHC’s cost / quality criteria will be instructed to make specific improvements or settle for “non-Designated” status (they’ll still be in-network).

Patient Incentives – UnitedHealthcare patients referred for advanced imaging will be automatically sent to Designated Diagnostic Providers, and will face far higher co-pays if they somehow find a non-Designated imaging center (e.g., $680 vs. $290 for a CT).

Designated Dilemma – UnitedHealthcare’s contracted imaging providers will now either have to adopt what are surely UHC-friendly policies, or brace for a lot less UHC patients. These Non-Designated Providers would also have to be okay with charging UHC patients far higher co-pays than if they went to a Designated Provider.

UHC’s Outpatient Push – UnitedHealthcare has been aggressively shifting patients away from hospitals and towards outpatient imaging centers for quite a while, and this latest move ensures that most of these outpatient exams will happen at its preferred imaging centers.

The Takeaway
One of the ways UnitedHealth Group achieved its massive growth was by steering patients to the highest-value procedures and treatments. The new Designated Diagnostic Provider program seems like a very effective way to apply that strategy to medical imaging coverage, even if many imaging providers might not like it.

Intermountain’s Imaging Centers

Posted on September 30, 2021October 13, 2023 by Jake Fishman

Intermountain Healthcare expanded into outpatient imaging with the launch of its new imaging center subsidiary, Tellica Imaging. Plenty of hospital systems have outpatient imaging centers, but how and why Intermountain created Tellica brings some important takeaways.

About Tellica – Tellica Imaging plans to open a fleet of outpatient MRI and CT centers, starting with three Utah locations by late 2021, five locations in 2022, and more locations in “subsequent years.” The Tellica centers will prioritize patient convenience and value, targeting easy-to-access locations and adopting a novel flat-rate pricing model that’s well below typical in-hospital rates.

The Value-Based Angle – Given Intermountain’s role as one of the country’s flagship value-based care systems and its unique payor-provider structure, launching a series of imaging centers that are lower cost and more convenient makes a lot of sense. It’s also a step away from the hospital-based/owned procedure trend that’s helped hospitals from a reimbursement perspective, but brought a long list of unintended consequences (higher patient/payor costs, provider consolidation, imaging overuse, etc.).

The Payor Angle – Even though many patients use Intermountain’s in-house insurer (SelectHealth), Intermountain also works with a long list of commercial and government payors, nearly all of which have been incentivizing (or forcing) health systems to move more imaging procedures to outpatient centers. SelectHealth likely has the same preferences.

The Offsite Trend – In addition to the above payor pressures, there are some major trends underway that favor offsite imaging, including the rapid adoption of at-home/remote patient care, new COVID-related offsite policies, and the federal government’s efforts to make healthcare procedures more “shoppable.”

The Takeaway – Hospital-owned outpatient imaging centers aren’t all that unique, but Intermountain’s structure definitely is (payor-provider, value-based, non-profit) and so is its decision to launch these centers with such a patient-friendly value proposition. Even if most hospitals aren’t yet ready to offer flat-rate scans, the factors that drove Intermountain to create Tellica are likely forcing plenty of other systems to rethink their own approach to offsite imaging.

Get every issue of The Imaging Wire, delivered right to your inbox.

This content is exclusive to subscribers